Vitura Health Limited (ASX: VIT) - ETF Exposure

Current share price for VIT : $0.020 0.004 (25%)⁺

Vitura Health Limited (VIT) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is involved in the operation of its digital health platform, Canview, the sale and distribution of medicinal cannabis and other products and the operation of its growing number of telehealth-based clinic businesses.

VIT General Information ⁺

ASX Code	VIT
Website	http://www.vitura.com.au
Industry/Sector	Pharmaceuticals
Market Cap ($M)	13
VIT Share Price	$0.020
Day High	$0.020
Day Low	$0.016
Last Close	$0.016
VIT Share Price Movement	$0.00 ( 25% )

Prices as at 16:40, 16 Oct 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Vitura Health Limited (VIT) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
HFResult	0.2¢	100%	5 Sep 2025	30 Sep 2025	-	-	-
HFResult	1¢	100%	4 Sep 2023	28 Sep 2023	-	-	-
HFResult	1¢	100%	16 Sep 2022	11 Oct 2022	-	-	-

See all dividends from Vitura Health Limited (VIT) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Vitura Health Limited (VIT) price-sensitive announcements

VIT - Q1 FY27 Operational Update

Vitura Health Limited’s Q1 FY2027 operational update reports an encouraging first quarter

Vitura Health Limited (VIT)
13 Oct 2026 | 8:18 AM

VIT - FY2026 Financial Results

Vitura Health Limited reported its FY2026 financial results, highlighting a year of solid

Vitura Health Limited (VIT)
26 Aug 2026 | 9:35 AM

VIT - ASX Appendix 4E Preliminary Final Report

Vitura Health Limited's ASX Appendix 4E Preliminary Final Report for the year ended 30 Jun

Vitura Health Limited (VIT)
26 Aug 2026 | 8:49 AM

VIT - Former CEO Legal Action Initiated

Vitura Health Limited, a diversified digital health business listed on the ASX, announced

Vitura Health Limited (VIT)
20 May 2026 | 9:37 AM

Vitura Health Limited (VIT) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Vitura Health Limited (VIT) ORDINARY FULLY PAID	Health Care	$13	Notification of cessation of securities - VIT	16 Oct 2026 8:39AM	$0.016	$0.020	risen by 25%
Vitura Health Limited (VIT) ORDINARY FULLY PAID	Health Care	$13	FY26 Annual Report	16 Oct 2026 8:26AM	$0.016	$0.020	risen by 25%
Vitura Health Limited (VIT) ORDINARY FULLY PAID	Health Care	$13	Q1 FY27 Operational Update	13 Oct 2026 8:18AM	$0.019	$0.020	risen by 5.26%
Vitura Health Limited (VIT) ORDINARY FULLY PAID	Health Care	$13	Commencement of Chief Financial Officer	29 Sep 2026 3:15PM	$0.019	$0.020	risen by 5.26%
Vitura Health Limited (VIT) ORDINARY FULLY PAID	Health Care	$13	2026 Annual General Meeting	21 Sep 2026 11:41AM	$0.019	$0.020	risen by 5.26%
Vitura Health Limited (VIT) ORDINARY FULLY PAID	Health Care	$13	Doctors on Demand Update	7 Sep 2026 11:59AM	$0.027	$0.020	fallen by 25.93%

VIT Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	PER	DPS	Yield (%)	Franking (%)
2026A	-$2.77	-$0.40	-180.80%	0.00	0.00	0.00%	0.0%
2025A	$2.88	$0.50	-89.40%	15.80	0.20	2.40%	100.0%
2024A	$27.76	$4.90	103.30%	5.50	0.00	0.00%	0.0%

VIT Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A
Clarity Pharmaceuticals Ltd (CU6)	$681M	0.4454	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Neuren Pharmaceuticals Limited (NEU)	$2,459M	-0.7857	0.2462	0.9655	83.3691	66.8966	34.0351	0.00%	1.70%	2.01%
Vitura Health Limited (VIT)	$13M	-1.8077	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%

VIT Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.00	0.00	0.24	0.00
Market	0.31	13.50	1.04	0.70
Sector	0.77	43.70	2.65	2.10

VIT Directors

Name	Position	Start Date
Mr Robert Iervasi	Non-Executive Chairman, Non-Executive Director	12 Feb 2024
Mr Shane Francis Tanner	Non-Executive Director	27 Nov 2024
Ms Rebecca Jayne Wilson	Non-Executive Director	27 Nov 2024
Mr Daniel Francis Birch	Non-Executive Director	27 Nov 2024

Vitura Health Limited (VIT) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
30 Sep 2025	FOGARTY, Gerard	Buy	Indirect Shares	10,428	$0.064	$663.951
4 Mar 2025	FOGARTY, Gerard	Buy	Indirect Shares	332,000	$0.075	$24,900.000
27 Feb 2025	WILSON, Rebecca	Buy	Indirect Shares	228,000	$0.087	$19,835.912

See all changes in directors' interest & trades for Vitura Health Limited (VIT) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

VIT Management

Name	Position
Ryan J. Tattle	Chief Revenue Officer
Geoff Cockerill	Chief Executive Officer
Michael Sapountzis	Company Secretary

VIT Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Vitura Health Limited (VIT). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
114,464,236 (17.28%)	AFO Investments Pty Ltd
85,621,544 (12.92%)	Benjamin David Ngahuia Jansen
55,176,065 (8.33%)	Cronos Global Holdings Inc
50,101,072 (7.56%)	Jessimine Charles Kiritea Jansen
50,101,079 (7.56%)	Guy Rothwell Headley
36,079,345 (5.44%)	Matua Hasyo Charlie Jansen

VIT Calendar of Events

Date	Event
25 August 2027	Report (Annual)
25 August 2027	Report (Prelim)
24 February 2027	Report (Interim)
21 October 2026	Report (Annual)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us